Estrogen receptor activation and estrogen-regulated gene expression are unaffected by methylseleninic acid in LNCaP prostate cancer cells
- 30 November 2007
- journal article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 18 (11) , 746-752
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of actionMolecular Cancer Therapeutics, 2006
- Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA)The Prostate, 2006
- Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesisToxicology Letters, 2006
- Intake of Selenium in the Prevention of Prostate Cancer: a Systematic Review and Meta-analysis*Cancer Causes & Control, 2005
- Endoplasmic Reticulum Stress Signal Mediators Are Targets of Selenium ActionCancer Research, 2005
- Chemoprevention of prostate cancerCritical Reviews in Oncology/Hematology, 2005
- Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer TrialBJU International, 2003
- Expression of ERα and ERβ in prostate cancerThe Prostate, 2003
- Structural regions of ERα critical for synergistic transcriptional responses contain co-factor interacting surfacesMolecular and Cellular Endocrinology, 2002
- Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cellsJournal of Molecular Endocrinology, 2001